Akebia Therapeutics announces VOICE trial data showing vadadustat improves safety outcomes for anemia in dialysis patients versus ESA.

In March 2024, Vafseo® (vadadustat), was approved by the U.S. Food and Drug Administration for the treatment of anemia due to chronic kidney disease in adults who have been receiving dialysis for at ...

Statins lower LDL cholesterol reliably, and for people with established heart disease or high cardiovascular risk, the ...

Three molecules of the statin atorvastatin can wedge into a single pocket on a calcium channel in muscle cells and hold it ...

A large BJO study links statin use to lower open-angle glaucoma risk and fewer surgeries or eye drops. Learn the data, limits ...

IF YOU’RE TAKING a statin to lower your cholesterol, you may have wondered whether the medication gives you a little more ...

Scientists have uncovered a surprising reason why statins, the widely prescribed cholesterol-lowering drugs that help prevent ...

The Truth About Drugs That Cut Off Supply Lines~In the previous installment (Part 7), we learned the realistic picture of ...

IntroductionI recently read a special feature on dyslipidemia in the 'Journal of the Japan Medical Association.' The story of how statins were discovered in Japan and grew into a global standard ...

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in ...

An update has been issued to people taking a common medication for cholesterol after research was published by the European Society of Cardiology (ESC). The research showed that Atorvastatin reduced ...